Delhi has less than a day’s stock of coronavirus vaccines left, with nearly 30,000 doses administered on July 19, according to a bulletin issued on Tuesday.
Topics
Coronavirus Vaccine | Delhi | Vaccination
Delhi has less than a day’s stock of coronavirus vaccines left, with nearly 30,000 doses administered on July 19, according to a bulletin issued on Tuesday.
The national capital, as on Tuesday morning, had a balance stock of 2,63,170 coronavirus vaccines, out of which 1,95,290 doses are of Covishield and 67,880 of Covaxin, data shared by the government showed.
However, only 20 per cent of the Covaxin stock is to be used, since its stock is limited and has irregular delivery cycles, it noted.
Only 25,986 doses were administered on Monday, of which 16,704 were first doses and 9,282 second doses.
As many as 93,83,468 vaccine doses have been administered in the national capital till date, including 22,25,292 are second doses.
Delhi’s current vaccination capacity stands at 47,605 doses per day.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
First Published: Wed, July 21 2021. 01:35 IST
read the full story about Delhi Covid-19 vaccine stock to last less than one day: Bulletin
#theheadlines #breakingnews #headlinenews #newstoday #latestnews #aajtak #ndtv #timesofindia #indiannews